Alexandra Roberts
Nurse Practitioner · Rochester, NHNPI 1629142963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 29.5% of the total. Among nurse practitioner clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$770
- Regeneron Healthcare Solutions, Inc.$451
- Takeda Pharmaceuticals U.S.A., Inc.$373
- CSL Behring$234
- Sanofi$213
- plus $959 from 14 others
What the payments were for
- Food & beverage$4,252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 59 | $1,253 |
| GSK | 40 | $770 |
| Regeneron Healthcare Solutions, Inc. | 17 | $451 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $373 |
| CSL Behring | 14 | $234 |
| Sanofi | 9 | $213 |
| Novartis | 8 | $140 |
| Genentech USA, Inc. | 7 | $137 |
| Pfizer | 7 | $137 |
| Boehringer Ingelheim | 6 | $114 |
| Mylan Specialty L.p. | 5 | $95 |
| Amgen | 4 | $83 |
| Grifols USA, LLC | 4 | $70 |
| Viatris Specialty LLC | 2 | $39 |
| Kaleo, Inc. | 2 | $32 |
| Phadia US Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 2 | $27 |
| Incyte Corporation | 1 | $21 |
| Pharming Healthcare, Inc. | 1 | $19 |
| Biocryst US Sales Co., LLC | 1 | $16 |
How this compares
$4,252 in reported general payments places this provider in the 95th percentile of 714 nurse practitioner providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 102 | $83,865 |
| XolairOmalizumab | 21 | $39,913 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $18,485 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $15,346 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,394 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,342 |
| Fluticasone Propionate | 47 | $1,095 |
| Montelukast Sodium | 67 | $460 |
| Ipratropium Bromide | 19 | $454 |
| Hydroxyzine Hcl | 19 | $206 |
| Levocetirizine Dihydrochloride | 12 | $126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $770 | $102,350133 claims |
| AstraZenecaBreztri Aerosphere | $1,253 | $15,34617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 nurse practitioner providers in New Hampshire.
Other nurse practitioner in Rochester
- Jessica St JeanPelham$302K
- Michael RobustelliSomersworth$17K
- Denise McGrathLebanon$7K
- Lisa WilliamsBedford$7K
- Shareen LucasPortsmouth$7K
- Sonya AlyeaSomersworth$6K
- Jessica PollackConcord$5K
- Jennifer GriffinNashua$5K
- Dawne HillsgroveNashua$4K
- Shelby MenardSomersworth$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.